RÉSUMÉ
Alterations in cardiac energy metabolism play a key role in the pathogenesis of diabetic cardiomyopathy. Hypercholesterolemia associated with bioenergetic impairment and oxidative stress has not been well characterized in the cardiac function under glycemic control deficiency conditions. This work aimed to determine the cardioprotective effects of quercetin (QUE) against the damage induced by a high-cholesterol (HC) diet in hyperglycemic rats, addressing intracellular antioxidant mechanisms and bioenergetics. Quercetin reduced HC-induced alterations in the lipid profile and glycemia in rats. In addition, QUE attenuated cardiac diastolic dysfunction (increased E:A ratio), prevented cardiac cholesterol accumulation, and reduced the increase in HC-induced myocyte density. Moreover, QUE reduced HC-induced oxidative stress by preventing the decrease in GSH/GSSG ratio, Nrf2 nuclear translocation, HO-1 expression, and antioxidant enzymatic activity. Quercetin also counteracted HC-induced bioenergetic impairment, preventing a reduction in ATP levels and alterations in PGC-1α, UCP2, and PPARγ expression. In conclusion, the mechanisms that support the cardioprotective effect of QUE in rats with HC might be mediated by the upregulation of antioxidant mechanisms and improved bioenergetics on the heart. Targeting bioenergetics with QUE can be used as a pharmacological approach to modulate structural and functional changes of the heart under hypercholesterolemic and hyperglycemic conditions.
Sujet(s)
Régime alimentaire/effets indésirables , Souffles cardiaques/prévention et contrôle , Hypercholestérolémie/traitement médicamenteux , Quercétine/pharmacologie , Animaux , Cholestérol/administration et posologie , Métabolisme énergétique , Souffles cardiaques/traitement médicamenteux , Souffles cardiaques/étiologie , Hypercholestérolémie/anatomopathologie , Hyperglycémie/étiologie , Hyperglycémie/physiopathologie , Mâle , Stress oxydatif , Répartition aléatoire , Rats , Rat WistarSujet(s)
Kystes/complications , Kystes/imagerie diagnostique , Échocardiographie/méthodes , Souffles cardiaques/étiologie , Insuffisance mitrale/complications , Insuffisance mitrale/imagerie diagnostique , Kystes/chirurgie , Diagnostic différentiel , Souffles cardiaques/diagnostic , Souffles cardiaques/prévention et contrôle , Humains , Mâle , Adulte d'âge moyen , Insuffisance mitrale/chirurgie , Résultat thérapeutiqueRÉSUMÉ
A breeding program with the aim of reducing the prevalence of mitral regurgitation (MR) caused by myxomatous mitral valve disease (MMVD) in Cavalier King Charles Spaniels (CKCS) is currently ongoing in Sweden. In this investigation 353 CKCS were selected as a sample of the population and 150 were examined by auscultation for heart murmurs when they reached the age of six years in 2007 and 2009. The aim with this investigation was to study the prevalence of heart murmurs in six-year-old CKCS and to estimate if prevalence has decreased since the breeding program was introduced 2001. The effect of the breeding program was evaluated by comparing the prevalence of heart murmurs in the two groups. In 2007, the prevalence of heart murmurs was 52% (50% for females and 54% for males) and in 2009, the prevalence was 55% (44% for females and 67% for males). No significant difference was found in the prevalence of heart murmurs between 2007 and 2009 (P=0.8). For all six-year-old CKCS, the prevalence of heart murmur was 53% (females 46% and males 61%), which is higher than previous Swedish investigations.
Sujet(s)
Maladies des chiens/génétique , Souffles cardiaques/médecine vétérinaire , Insuffisance mitrale/médecine vétérinaire , Animaux , Sélection/méthodes , Maladies des chiens/prévention et contrôle , Chiens , Femelle , Auscultation cardiaque/médecine vétérinaire , Souffles cardiaques/épidémiologie , Souffles cardiaques/génétique , Souffles cardiaques/prévention et contrôle , Modèles logistiques , Mâle , Insuffisance mitrale/épidémiologie , Insuffisance mitrale/génétique , Insuffisance mitrale/prévention et contrôle , Prévalence , Suède/épidémiologieRÉSUMÉ
We describe a 5-month old infant who presented with a continuous murmur and enlargement of the left heart. The patient's diagnosis was an anomalous systemic arterial supply to basal segments of the left lower lobe characterized by a lack of a pulmonary arterial supply. This condition was treated without lobectomy. To our knowledge, this report is the first to describe an anomalous systemic arterial supply to basal segments of the lower lobe of the left lung with a single arterial supply that was treated in childhood without lung resection. Our case offers an alternative treatment to surgical lobectomy for this abnormality.
Sujet(s)
Souffles cardiaques/étiologie , Souffles cardiaques/prévention et contrôle , Poumon/vascularisation , Poumon/chirurgie , Artère pulmonaire/malformations , Artère pulmonaire/chirurgie , Procédures de chirurgie vasculaire/méthodes , Femelle , Humains , Nouveau-né , Résultat thérapeutiqueSujet(s)
Maladies des chats/épidémiologie , Cardiopathies/médecine vétérinaire , Souffles cardiaques/médecine vétérinaire , Animaux , Maladies des chats/prévention et contrôle , Chats , Cardiopathies/épidémiologie , Cardiopathies/prévention et contrôle , Souffles cardiaques/épidémiologie , Souffles cardiaques/prévention et contrôle , PrévalenceRÉSUMÉ
OBJECTIVE: To compare the efficacy of injections of 1.2 million units of benzathine penicillin G given every 3 weeks versus every 4 weeks for secondary prevention of rheumatic fever, based on the long-term outcome of patients receiving such prophylaxis. METHODS: A total of 249 consecutive patients with rheumatic fever, randomly assigned to either a 3-week or a 4-week regimen, were examined every 3 to 6 months, and followed for 794 and 775 patient-years, respectively. RESULTS: Compliance with each regimen was comparable: 83 (66.9%) of 124 patients in the 3-week group versus 92 (73.6%) of 125 patients in the 4-week group stayed in the program (p > 0.05). Streptococcal infections occurred less frequently in those receiving the 3-week regimen: 7.5 versus 12.6 per 100 patient-years (p < 0.01). Prophylaxis failed in 2 patients receiving the 3-week regimen and in 10 receiving the 4-week regimen (0.25 and 1.29 per 100 patient-years respectively; p = 0.015). Serum penicillin levels were adequate (> or = 0.02 micrograms/ml) in 100 (56%) of 179 samples obtained 21 days after penicillin injection in the 3-week regimen, and in 51 (33%) of 155 samples obtained 28 days after injection in the 4-week regimen (p < 0.01). Of 71 patients with mitral regurgitation in the 3-week regimen, 47 (66%) no longer had the murmur; of 87 patients in the 4-week regimen, 40 (46%) no longer had the murmur (p < 0.05). CONCLUSIONS: This 12-year controlled study indicates that the outcome of patients with rheumatic fever is better with a 3-week than with a 4-week penicillin prophylaxis regimen. Greater emphasis and more widespread use of the 3-week regimen should be recommended.